Eli Lilly and Co
LLY
Eli Lilly and Co News & Analysis
stocks
Eli Lilly earnings: Mounjaro/Zepbound’s massive volume growth more than counters price pressure
We’ve raised our fair value estimate of Lilly stock.
stocks
A wave of US biotech IPOs may be starting - here’s why
M&A activity is bolstering IPOs within key areas of the biotech space. A GLP-1 maker and a protein biomarker detection company are the latest.
stocks
Eli Lilly receives FDA approval to add another oral GLP-1 to market
Wide moat Eli Lilly receives FDA approval for obesity pill.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,969.80 | 23.20 | 0.26% |
| CAC 40 | 8,123.73 | 59.61 | -0.73% |
| DAX 40 | 24,989.13 | 115.57 | -0.46% |
| Dow JONES (US) | 50,891.65 | 140.81 | -0.28% |
| FTSE 100 | 10,321.89 | 87.39 | -0.84% |
| HKSE | 25,398.18 | 215.79 | 0.86% |
| NASDAQ | 27,013.29 | 40.67 | 0.15% |
| Nikkei 225 | 66,934.33 | 604.83 | 0.91% |
| NZX 50 Index | 13,244.55 | 38.44 | 0.29% |
| S&P 500 | 7,579.43 | 0.63 | -0.01% |
| S&P/ASX 200 | 8,729.40 | 19.40 | 0.22% |
| SSE Composite Index | 4,057.74 | 10.83 | -0.27% |